Amicus Therapeutics
FOLD
FOLD was delisted on the 24th of April, 2026.
69 hedge funds and large institutions have $81.1M invested in Amicus Therapeutics in 2013 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 22 reducing their positions, and 11 closing their positions.
357% more call options, than puts
Call options by funds: $274K | Put options by funds: $60K
16% more capital invested
Capital invested by funds: $69.6M → $81.1M (+$11.5M)
5% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 22
4% less funds holding
Funds holding: 72 → 69 (-3)
5.02% less ownership
Funds ownership: 60.44% → 55.42% (-5%)
27% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$13.6M |
| 2 |
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO)
Irvine,
California
|
+$424K |
| 3 |
D.E. Shaw & Co
New York
|
+$411K |
| 4 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
+$252K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$217K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$1.35M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.28M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.02M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$483K |
| 5 |
First Manhattan
New York
|
-$355K |
FOLD Hedge Fund Activity: Q4 2013 in Review
69 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q4 2013, worth a combined $81.1M — up 16% from $69.6M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of FOLD and 8 opened new positions — a net loss of 3 holders — while 22 trimmed existing stakes and 23 added.
The largest buyer was Redmile Group, adding an estimated $13.6M. The largest seller was Palo Alto Investors, cutting an estimated $1.35M.
- 69 institutional investors held Amicus Therapeutics (FOLD) as of Q4 2013, down from 72 in Q3 2013.
- Funds reported $81.1M of Amicus Therapeutics stock for Q4 2013, up 16% quarter-over-quarter.
- 8 funds opened new Amicus Therapeutics positions in Q4 2013 and 11 closed out, a net change of -3 holders.
- The largest Amicus Therapeutics buyer in Q4 2013 was Redmile Group, an estimated $13.6M added.
- The largest Amicus Therapeutics seller in Q4 2013 was Palo Alto Investors, an estimated $1.35M sold.
Based on aggregated 13F filings for Q4 2013.